1. Home
  2. LEO vs ZVRA Comparison

LEO vs ZVRA Comparison

Compare LEO & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEO
  • ZVRA
  • Stock Information
  • Founded
  • LEO 1987
  • ZVRA 2006
  • Country
  • LEO United States
  • ZVRA United States
  • Employees
  • LEO N/A
  • ZVRA N/A
  • Industry
  • LEO Trusts Except Educational Religious and Charitable
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEO Finance
  • ZVRA Health Care
  • Exchange
  • LEO Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • LEO N/A
  • ZVRA 400.8M
  • IPO Year
  • LEO N/A
  • ZVRA 2015
  • Fundamental
  • Price
  • LEO $5.95
  • ZVRA $7.79
  • Analyst Decision
  • LEO
  • ZVRA Strong Buy
  • Analyst Count
  • LEO 0
  • ZVRA 8
  • Target Price
  • LEO N/A
  • ZVRA $22.29
  • AVG Volume (30 Days)
  • LEO 200.2K
  • ZVRA 454.0K
  • Earning Date
  • LEO 01-01-0001
  • ZVRA 05-13-2025
  • Dividend Yield
  • LEO 4.01%
  • ZVRA N/A
  • EPS Growth
  • LEO N/A
  • ZVRA N/A
  • EPS
  • LEO 0.04
  • ZVRA N/A
  • Revenue
  • LEO N/A
  • ZVRA $23,612,000.00
  • Revenue This Year
  • LEO N/A
  • ZVRA $267.44
  • Revenue Next Year
  • LEO N/A
  • ZVRA $90.10
  • P/E Ratio
  • LEO $152.00
  • ZVRA N/A
  • Revenue Growth
  • LEO N/A
  • ZVRA N/A
  • 52 Week Low
  • LEO $4.98
  • ZVRA $4.20
  • 52 Week High
  • LEO $6.50
  • ZVRA $9.76
  • Technical
  • Relative Strength Index (RSI)
  • LEO 54.70
  • ZVRA 56.79
  • Support Level
  • LEO $5.79
  • ZVRA $7.26
  • Resistance Level
  • LEO $5.94
  • ZVRA $8.10
  • Average True Range (ATR)
  • LEO 0.08
  • ZVRA 0.36
  • MACD
  • LEO 0.03
  • ZVRA 0.08
  • Stochastic Oscillator
  • LEO 100.00
  • ZVRA 75.20

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: